Uveitis Not Yet Recruiting Phase 4 Trials for Adalimumab (DB00051)

Also known as: Unspecified iridocyclitis / Uveitis NOS / Uveitis (disorder)

IndicationStatusPhase
DBCOND0009937 (Uveitis)Not Yet Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT06390436Therapeutic Drug Monitoring-baSed adalimuMab De-escalatiOn in nOn-infecTious cHronic UveitisTreatment
NCT05105347Efficacy and Safety of Adalimumab Plus Medium Dose Oral Glucocorticosteroid for Refractory Beh├žet's UveitisTreatment